Our vaccine products meet all required efficacy criteria set forth in national and international standards and requirements.
3Fluart seasonal influenza vaccine (whole virion, inactivated, adjuvanted):
Since the influenza season of 2015/16 Fluart introduced to the market a brand-new development seasonal flu vaccine, the 3Fluart with lowered active ingredient (6 micrograms/strain) replacing previous 15 micrograms product FluvalAB.
1Fluart (H1N1 pandemic) influenza vaccine (formerly called Fluval P (H1N1) pandemic influenza vaccine; whole virion, inactivated, adjuvanted
Fluart produced its Fluval P (H1N1 pandemic) vaccine in large quantities (6.5 million doses compared to the population of Hungary, which is 10 million people) during the H1N1 pandemic in 2009. The vaccine was characterized by low active ingredient content (6µg HA).
Over 35 million doses of seasonal and pandemic influenza vaccines have been produced and administered so far.